Brand / product

STIVANT

Bevacizumab · 100 mg

₨ Official source-observed price PKR 25,715.63 1's

PKR 25,715.63 / vial/unit

✓ Official DRAP price source observed · Source checked 2026-10-10

Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →

This brandPKR 25,715.63/ vial/unit

Price positionNo comparatorvs like-for-like peer median

Peer comparators0current-price listings

Normalized unit pricePKR 25,715.63 / vial/unit

No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic: Bevacizumab
Therapeutic area: Oncology & immunology
Drug class: Antineoplastic medicines
ATC: L01
Strength: 100 mg
Dosage form: Injection
Pack: 1's
Registration no.: 107905
Price record verified: 2026-08-08
Latest DRAP source check: 2026-10-10 03:32

Manufacturer

CCL Pharmaceuticals (Pvt.) Limited

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Summary

About STIVANT 100 mg injection

STIVANT 100 mg injection contains Bevacizumab 100 mg. It is registered with DRAP by CCL Pharmaceuticals (Pvt.) Limited (registration no. 107905). Its official price is PKR 25,715.63 for a pack of 1's. This price has applied since 23 July 2026. STIVANT is also available as 400 mg/16 mL concentrate for solution for infusion. No other brand of Bevacizumab 100 mg in this form is listed in Pakistan.

Same brand

Other strengths of STIVANT

STIVANT 400 mg/16 mLConcentrate for solution for infusion · 1's · PKR 102,238.25

Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (1's). Current price PKR 25,715.63, effective 23 Jul 2026.

Cite this price history

MedInfoBase. STIVANT 100 mg, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/stivant-100-mg-107905-1s-ccl-pharmaceuticals-pvt-ltd/ (accessed 10 October 2026).

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 25,715.63	2026-07-23	2026-08-08	DRAP PharmaPrice Index	Current

Same generic

Other listed brands

ABEVMY 100 mg/4 mLAGP Limited · PKR 25,715.62 Abevmy 400 400 mg/16 mL (25 mg/mL)AGP Limited · PKR 102,238.25 Arketin 100 mg/4 mLRA Healthcare (SMC-Pvt) Ltd · PKR 17,674.07 Avastin 400 mg/16 mLRoche Pakistan Ltd · PKR 236,486.52 Avastin 100 mg/4 mLRoche Pakistan Ltd · PKR 59,483.08 BAZUMAB 100 mg/4 mLHilton Pharma (Pvt) Limited. · PKR 23,067.95 BAZUMAB 400 mg/16 mLHilton Pharma (Pvt) Limited. · PKR 91,711.79 Bevec 100 mg/4 mL (25 mg/mL)PHARMEVO (PVT) LTD. · PKR 25,715.63

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 107905

MedInfoBase. (2026). STIVANT 100 mg Injection (1's), CCL Pharmaceuticals (Pvt.) Limited — registration and price record [Data set]. MedInfoBase. Retrieved October 10, 2026, from https://medinfobase.com/brand/stivant-100-mg-107905-1s-ccl-pharmaceuticals-pvt-ltd/ Data observed 8 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 107905.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.